Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypersensitivity Reaction

  Free Subscription


Articles published in Allergy Asthma Proc

Retrieve available abstracts of 102 articles:
HTML format
Text format



Single Articles


    March 2019
  1. SOYYIGIT S, Arslan S, Caliskaner AZ
    Investigation of the factors that determine the severity of allergic reactions to Hymenoptera venoms.
    Allergy Asthma Proc. 2019;40:116-122.
    PubMed     Text format     Abstract available


  2. KIM J, Kim BE, Leung DYM
    Pathophysiology of atopic dermatitis: Clinical implications.
    Allergy Asthma Proc. 2019;40:84-92.
    PubMed     Text format     Abstract available


  3. BELLANTI JA
    Genetics/epigenetics/allergy: The gun is loaded ... but what pulls the trigger?
    Allergy Asthma Proc. 2019;40:76-83.
    PubMed     Text format     Abstract available


  4. BELLANTI JA, Settipane RA
    Genetics, epigenetics, and allergic disease: A gun loaded by genetics and a trigger pulled by epigenetics.
    Allergy Asthma Proc. 2019;40:73-75.
    PubMed     Text format    


    January 2019
  5. SHA L, Shao M, Liu C, Wu Y, et al
    A cross-sectional study of the prevalence of food allergies among children younger than ages 14 years in a Beijing urban region.
    Allergy Asthma Proc. 2019;40:e1-e7.
    PubMed     Text format     Abstract available



  6. Abstracts presented at the New England Society of Allergy, October 20-21, 2018, Plymouth MA.
    Allergy Asthma Proc. 2019;40:71.
    PubMed     Text format    


  7. KURUVILLA M, Shih J, Patel K, Scanlon N, et al
    Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy.
    Allergy Asthma Proc. 2019;40:57-61.
    PubMed     Text format     Abstract available


  8. SUNDQUIST BK, Jose J, Pauze D, Pauze D, et al
    Anaphylaxis risk factors for hospitalization and intensive care: A comparison between adults and children in an upstate New York emergency department.
    Allergy Asthma Proc. 2019;40:41-47.
    PubMed     Text format     Abstract available


  9. HAR D, Lee MJ
    Systemic reaction rates with omalizumab, subcutaneous immunotherapy, and combination therapy in children with allergic asthma.
    Allergy Asthma Proc. 2019;40:35-40.
    PubMed     Text format     Abstract available


  10. COOK QS, Kim EH
    Update on peanut allergy: Prevention and immunotherapy.
    Allergy Asthma Proc. 2019;40:14-20.
    PubMed     Text format     Abstract available


  11. BELLANTI JA, Settipane RA
    Inflammation and allergic disease: An irrefutable combination.
    Allergy Asthma Proc. 2019;40:1-3.
    PubMed     Text format    


    December 2018
  12. ALVARADO SA, Nassiri M, Bahna SL
    Scoring systems for allergies and asthma in clinical research and practice.
    Allergy Asthma Proc. 2018 Dec 18. doi: 10.2500/aap.2019.40.4196.
    PubMed     Text format     Abstract available


    November 2018
  13. ZHANG B, Liu J, Dong Y, Guo B, et al
    Extrinsic warming of low-osmolality iodinated contrast media to 37 degrees C reduced the rate of allergic-like reaction.
    Allergy Asthma Proc. 2018;39:e55-e63.
    PubMed     Text format     Abstract available


  14. SARDECKA I, Los-Rycharska E, Ludwig H, Gawryjolek J, et al
    Early risk factors for cow's milk allergy in children in the first year of life.
    Allergy Asthma Proc. 2018;39:e44-e54.
    PubMed     Text format     Abstract available


  15. RANDHAWA I, Morphew T, Marsteller NL
    Correlation of negative skin-prick test results for tree nuts and successful tree nut challenges among children with peanut allergy.
    Allergy Asthma Proc. 2018;39:456-460.
    PubMed     Text format     Abstract available


  16. KITSIOULIS NA, Papadopoulos NG, Kostoudi S, Manousakis E, et al
    Assessment of atopic dermatitis as a risk factor for chronic spontaneous urticaria in a pediatric population.
    Allergy Asthma Proc. 2018;39:445-448.
    PubMed     Text format     Abstract available


  17. REILLY CA, Backer G, Basta D, Riblet NBV, et al
    The effect of preoperative penicillin allergy testing on perioperative non-beta-lactam antibiotic use: A systematic review and meta-analysis.
    Allergy Asthma Proc. 2018;39:420-429.
    PubMed     Text format     Abstract available


  18. KWON CW, Beck LA
    Severe atopic dermatitis: Therapeutic update.
    Allergy Asthma Proc. 2018;39:411-419.
    PubMed     Text format     Abstract available


  19. REED B, Blaiss MS
    The burden of atopic dermatitis.
    Allergy Asthma Proc. 2018;39:406-410.
    PubMed     Text format     Abstract available


  20. BELLANTI JA, Settipane RA
    Atopic dermatitis: A disease "More common in families that sneeze and wheeze".
    Allergy Asthma Proc. 2018;39:403-405.
    PubMed     Text format    


    September 2018
  21. BAKER JW, Bernstein JA, Harper JR, Relan A, et al
    Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
    Allergy Asthma Proc. 2018;39:359-364.
    PubMed     Text format     Abstract available


  22. LI HH, Mycroft S, Christiansen S, Wood DN, et al
    Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial.
    Allergy Asthma Proc. 2018;39:365-370.
    PubMed     Text format     Abstract available



  23. Abstracts from the Eastern Allergy Conference, May 31-June 3, 2018, Palm Beach, Florida.
    Allergy Asthma Proc. 2018;39:399-401.
    PubMed     Text format    


  24. MOSS RB, Moll T, Daniels K, Carlo DJ, et al
    Human factors study of a newly approved prefilled syringe of epinephrine for the treatment of anaphylaxis.
    Allergy Asthma Proc. 2018;39:389-393.
    PubMed     Text format     Abstract available


  25. EHLAYEL M, Bener A
    Camel's milk allergy.
    Allergy Asthma Proc. 2018;39:384-388.
    PubMed     Text format     Abstract available


  26. TUANO KTS, Anvari S, Hanson IC, Hajjar J, et al
    Improved diagnostic clarity in shrimp allergic non-dust-mite sensitized patients.
    Allergy Asthma Proc. 2018;39:377-383.
    PubMed     Text format     Abstract available


  27. SAHINER UM, Buyuktiryaki B, Gungor HE, Sahiner N, et al
    Factors that predict disease severity in atopic dermatitis: The role of serum basal tryptase.
    Allergy Asthma Proc. 2018;39:371-376.
    PubMed     Text format     Abstract available



  28. For the Patient.
    Allergy Asthma Proc. 2018;39:398.
    PubMed     Text format    


  29. LIU Y, Zhang S, Chen R, Wei J, et al
    Meta-analysis of randomized controlled trials for the efficacy and safety of anti-interleukin-13 therapy with lebrikizumab in patients with uncontrolled asthma.
    Allergy Asthma Proc. 2018;39:332-337.
    PubMed     Text format     Abstract available


  30. BELLANTI JA, Settipane RA
    Hereditary angioedema revisited.
    Allergy Asthma Proc. 2018;39:329-331.
    PubMed     Text format    


    August 2018
  31. ARNOLD RJG, Layton A, Massanari M
    Cost impact of monitoring exhaled nitric oxide in asthma management.
    Allergy Asthma Proc. 2018 Aug 13. doi: 10.2500/aap.2018.39.4165.
    PubMed     Text format     Abstract available


  32. DUBUSKE L, Newbold P, Wu Y, Trudo F, et al
    Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab.
    Allergy Asthma Proc. 2018 Aug 4. doi: 10.2500/aap.2018.39.4162.
    PubMed     Text format     Abstract available


    July 2018
  33. MILLER SD, Nyberg J, Siddiqui S, Dorinsky P, et al
    Randomized dose-ranging study of a budesonide metered-dose inhaler by using co-suspension delivery technology in asthma.
    Allergy Asthma Proc. 2018 Jul 23. doi: 10.2500/aap.2018.39.4155.
    PubMed     Text format     Abstract available


  34. CHOI YJ, Kang HN, Kim JH, Oh JW, et al
    Differences in cytokine levels between the nasal polyps of adolescents with local allergic and adolescents with allergic or nonallergic rhinitis.
    Allergy Asthma Proc. 2018;39:e30-e37.
    PubMed     Text format     Abstract available


  35. CASTILANO A, Sternard B, Cummings ED, Shi R, et al
    Pitfalls in anaphylaxis diagnosis and management at a university emergency department.
    Allergy Asthma Proc. 2018;39:316-321.
    PubMed     Text format     Abstract available


  36. ANTERASIAN CM, Geng B
    Penicillin skin testing in the management of penicillin allergy in an outpatient pediatric population.
    Allergy Asthma Proc. 2018;39:305-310.
    PubMed     Text format     Abstract available


  37. NAGARAJAN S, Ahmad S, Quinn M, Agrawal S, et al
    Allergic sensitization and clinical outcomes in urban children with asthma, 2013-2016.
    Allergy Asthma Proc. 2018;39:281-288.
    PubMed     Text format     Abstract available


  38. NELSON HS
    Immunotherapy for house-dust mite allergy.
    Allergy Asthma Proc. 2018;39:264-272.
    PubMed     Text format     Abstract available


  39. GHEZZI M, Tenero L, Piazza M, Zaffanello M, et al
    Feasibility of structured light plethysmography for the evaluation of lung function in preschool children with asthma.
    Allergy Asthma Proc. 2018;39:e38-e42.
    PubMed     Text format     Abstract available



  40. For the Patient.
    Allergy Asthma Proc. 2018;39:326.
    PubMed     Text format    


  41. POLA-BIBIAN B, Dominguez-Ortega J, Vila-Nadal G, Entrala A, et al
    Predictors of asthma relapse in patients who attended an emergency department.
    Allergy Asthma Proc. 2018;39:292-298.
    PubMed     Text format     Abstract available


  42. MCCALLISTER M, Medrano R, Wojcicki J
    Early life obesity increases the risk for asthma in San Francisco born Latina girls.
    Allergy Asthma Proc. 2018;39:273-280.
    PubMed     Text format     Abstract available


  43. BELLANTI JA, Settipane RA
    Children are not small adults.
    Allergy Asthma Proc. 2018;39:261-263.
    PubMed     Text format    


    May 2018
  44. WILLIAMS P, Kavati A, Pilon D, Xiao Y, et al
    Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States.
    Allergy Asthma Proc. 2018;39:201-211.
    PubMed     Text format     Abstract available


  45. EGHRARI-SABET J, Sher E, Kavati A, Pilon D, et al
    Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States.
    Allergy Asthma Proc. 2018;39:191-200.
    PubMed     Text format     Abstract available



  46. Abstracts from the Western Society of Allergy, Asthma, and Immunology (WSAAI) Annual Scientific Session, Kapalua, Hawaii, January 21-25, 2018.
    Allergy Asthma Proc. 2018;39:258.
    PubMed     Text format    


  47. SACCO KA, Chirila R, Libertin C, Hiroto B, et al
    Utilization and timeliness of an inpatient penicillin allergy evaluation.
    Allergy Asthma Proc. 2018;39:245-251.
    PubMed     Text format     Abstract available


  48. MA JE, Zhang N, El-Azhary RA, Fonacier L, et al
    Prevalence of allergen sensitization detected by patch tests.
    Allergy Asthma Proc. 2018;39:240-244.
    PubMed     Text format     Abstract available


  49. FRANCESCHINI F, Bottau P, Caimmi S, Cardinale F, et al
    Evaluating children with suspected allergic reactions to vaccines for infectious diseases.
    Allergy Asthma Proc. 2018;39:177-183.
    PubMed     Text format     Abstract available


  50. BELLANTI JA, Settipane RA
    The Floralia: A festive time for Romans and a demanding time for the allergist/immunologist.
    Allergy Asthma Proc. 2018;39:167-168.
    PubMed     Text format    


  51. YAVUZ ST, Siebert S, Akin O, Arslan M, et al
    Perinatal risk factors for asthma in children with allergic rhinitis and grass pollen sensitization.
    Allergy Asthma Proc. 2018;39:1-7.
    PubMed     Text format     Abstract available


  52. RAUSCHER C, Freeman A
    Drug-induced eosinophilia.
    Allergy Asthma Proc. 2018;39:252-256.
    PubMed     Text format     Abstract available


  53. PATEL P, Salapatek AM, Talluri RS, Tantry SK, et al
    Pharmacokinetics of intranasal olopatadine in the fixed-dose combination GSP301 versus two monotherapy intranasal olopatadine formulations.
    Allergy Asthma Proc. 2018;39:224-231.
    PubMed     Text format     Abstract available


  54. BANERJI A, Li Y, Busse P, Riedl MA, et al
    Hereditary angioedema from the patient's perspective: A follow-up patient survey.
    Allergy Asthma Proc. 2018;39:212-223.
    PubMed     Text format     Abstract available


  55. KAPLAN AP
    Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria.
    Allergy Asthma Proc. 2018;39:184-190.
    PubMed     Text format     Abstract available


  56. WEINBERGER M, Hendeles L
    Nonprescription medications for respiratory symptoms: Facts and marketing fictions.
    Allergy Asthma Proc. 2018;39:169-176.
    PubMed     Text format     Abstract available


  57. GUO X, Li Z, Ling W, Long J, et al
    Epidemiology of childhood asthma in mainland China (1988-2014): A meta-analysis.
    Allergy Asthma Proc. 2018;39:15-29.
    PubMed     Text format     Abstract available


  58. CHINELLATO I, Piazza M, Sandri M, Paiola G, et al
    Correlation between vitamin D serum levels and passive smoking exposure in children with asthma.
    Allergy Asthma Proc. 2018;39:8-14.
    PubMed     Text format     Abstract available



  59. For the Patient.
    Allergy Asthma Proc. 2018;39:257.
    PubMed     Text format    


    March 2018
  60. WHITE MV
    Guidance for compassionate restraint of small children to prevent injuries with epinephrine autoinjectors.
    Allergy Asthma Proc. 2018;39:161-165.
    PubMed     Text format     Abstract available



  61. Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria.
    Allergy Asthma Proc. 2018 Mar 20. doi: 10.2500/aap.2018.39.4136.
    PubMed     Text format     Abstract available


  62. PETRA AI, Tsilioni I, Taracanova A, Katsarou-Katsari A, et al
    Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.
    Allergy Asthma Proc. 2018;39:153-160.
    PubMed     Text format     Abstract available


  63. LAWLESS OJ, Bellanti JA, Brown ML, Sandberg K, et al
    In vitro induction of T regulatory cells by a methylated CpG DNA sequence in humans: Potential therapeutic applications in allergic and autoimmune diseases.
    Allergy Asthma Proc. 2018;39:143-152.
    PubMed     Text format     Abstract available


  64. MAGEN E, Chikovani T, Waitman DA, Kahan NR, et al
    Association of alopecia areata with atopic dermatitis and chronic spontaneous urticaria.
    Allergy Asthma Proc. 2018;39:96-102.
    PubMed     Text format     Abstract available


  65. BELLANTI JA, Settipane RA
    Allergic diseases: A collection of interactive immunologic disorders at the crossroads of genetics, environment, and immunity.
    Allergy Asthma Proc. 2018;39:83-85.
    PubMed     Text format    


  66. BERGER W, Sher E, Gawchik S, Fineman S, et al
    Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
    Allergy Asthma Proc. 2018;39:110-116.
    PubMed     Text format     Abstract available


  67. WANG J, Ke R, Shi W, Yan X, et al
    Association between psoriasis and asthma risk: A meta-analysis.
    Allergy Asthma Proc. 2018;39:103-109.
    PubMed     Text format     Abstract available


  68. MINCIULLO PL, Cascio A, Gangemi S
    Association between urticaria and nematode infections.
    Allergy Asthma Proc. 2018;39:86-95.
    PubMed     Text format     Abstract available


    January 2018

  69. Randomized trial to assess the efficacy and safety of beclomethasone dipropionate breath-actuated inhaler in patients with asthma.
    Allergy Asthma Proc. 2018 Jan 9. doi: 10.2500/aap.2018.39.4115.
    PubMed     Text format     Abstract available


  70. MELTZER EO, Berger WE
    A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.
    Allergy Asthma Proc. 2018;39:14-26.
    PubMed     Text format     Abstract available


  71. ZHANG X, Zheng J, Zhang L, Liu Y, et al
    Systemic inflammation mediates the detrimental effects of obesity on asthma control.
    Allergy Asthma Proc. 2018;39:43-50.
    PubMed     Text format     Abstract available


  72. TOPCU ZIK, Kaklikkaya N, Baki A, Orhan F, et al
    Characteristics of beef allergy in schoolchildren in Turkey.
    Allergy Asthma Proc. 2018;39:59-65.
    PubMed     Text format     Abstract available


  73. ASSAYAG M, Moshel S, Kohan M, Berkman N, et al
    The effect of omalizumab treatment on the low affinity immunoglobulin E receptor (CD23/fc epsilon RII) in patients with severe allergic asthma.
    Allergy Asthma Proc. 2018;39:36-42.
    PubMed     Text format     Abstract available


  74. BAHNA SL, Burkhardt JG
    The dilemma of allergy to food additives.
    Allergy Asthma Proc. 2018;39:3-8.
    PubMed     Text format     Abstract available


  75. JOSE J, Lehman EB, Craig T
    Evaluating satisfaction of patients with hereditary angioedema with their past and present treatments: Implications for future therapies.
    Allergy Asthma Proc. 2018;39:74-80.
    PubMed     Text format     Abstract available


  76. JERZYNSKA J, Stelmach W, Majak P, Stelmach R, et al
    Comparison of the effect of 5-grass pollen sublingual immunotherapy tablets and drops in children with rhinoconjunctivitis.
    Allergy Asthma Proc. 2018;39:66-73.
    PubMed     Text format     Abstract available


  77. PATEL B, Wi CI, Hasassri ME, Divekar R, et al
    Heterogeneity of asthma and the risk of celiac disease in children.
    Allergy Asthma Proc. 2018;39:51-58.
    PubMed     Text format     Abstract available


  78. STONE B, Davis JR, Trudo F, Schiffman B, et al
    Characterizing patients with asthma who received Global Initiative for Asthma steps 4-5 therapy and managed in a specialty care setting.
    Allergy Asthma Proc. 2018;39:27-35.
    PubMed     Text format     Abstract available


  79. BELLANTI JA, Settipane RA
    Unraveling the conundrum of asthma phenotypes and endotypes.
    Allergy Asthma Proc. 2018;39:1-2.
    PubMed     Text format    


    December 2017

  80. Asthma control, lung function, symptoms, and corticosteroid sparing after omalizumab initiation in patients with allergic asthma.
    Allergy Asthma Proc. 2017 Dec 5. doi: 10.2500/aap.2018.39.4111.
    PubMed     Text format     Abstract available


    November 2017

  81. The age-related characteristics of adults with asthma who visited emergency departments in Korea from 2007 to 2012.
    Allergy Asthma Proc. 2017 Nov 28. doi: 10.2500/aap.2018.39.4108.
    PubMed     Text format     Abstract available


  82. HUANG F, Yin JN, Wang HB, Liu SY, et al
    Association of imbalance of effector T cells and regulatory cells with the severity of asthma and allergic rhinitis in children.
    Allergy Asthma Proc. 2017;38:70-77.
    PubMed     Text format     Abstract available


    September 2017

  83. Evaluation of beclomethasone dipropionate (80 and 160 micrograms/day) delivered via a breath-actuated inhaler for persistent asthma.
    Allergy Asthma Proc. 2017 Sep 8. doi: 10.2500/aap.2017.38.4089.
    PubMed     Text format     Abstract available


    August 2017

  84. Indicators of poorly controlled asthma and health-related quality of life among school-age children in the United States.
    Allergy Asthma Proc. 2017 Aug 11. doi: 10.2500/aap.2017.38.4084.
    PubMed     Text format     Abstract available


    July 2017
  85. VANDEWALKER M, Hickey L, Small CJ
    Efficacy and safety of beclomethasone dipropionate breath-actuated or metered-dose inhaler in pediatric patients with asthma.
    Allergy Asthma Proc. 2017 Jul 14. doi: 10.2500/aap.2017.38.4078.
    PubMed     Text format     Abstract available



  86. Abstracts from the New England Society of Allergy Spring Meeting, April 7, 2017, Westford, MA.
    Allergy Asthma Proc. 2017;38:329-330.
    PubMed     Text format    


  87. OCHOA S, Cheng K, Fleury CM, Luccioli S, et al
    A 28-year-old woman with fever, rash, and pancytopenia.
    Allergy Asthma Proc. 2017;38:322-327.
    PubMed     Text format     Abstract available


  88. FAJT ML, Rosenberg SL, Yecies E, Traister RS, et al
    A 10-year experience of a novel and safe modified environmental rush immunotherapy protocol.
    Allergy Asthma Proc. 2017;38:309-316.
    PubMed     Text format     Abstract available


  89. KIM M, Kim YM, Lee JY, Yang HK, et al
    Seasonal variation and monthly patterns of skin symptoms in Korean children with atopic eczema/dermatitis syndrome.
    Allergy Asthma Proc. 2017;38:294-299.
    PubMed     Text format     Abstract available


  90. MORALES-SUAREZ-VARELA M, Llopis-Gonzalez A, Vergara-Hernandez C, Fernandez-Fabrellas E, et al
    Asthma in older people hospitalized with influenza in Spain: A case-control study.
    Allergy Asthma Proc. 2017;38:277-285.
    PubMed     Text format     Abstract available


    June 2017
  91. D SHER L, Yiu G, Sakov A, Liu S, et al
    Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
    Allergy Asthma Proc. 2017 Jun 21. doi: 10.2500/aap.2017.38.4069.
    PubMed     Text format     Abstract available


  92. CORREN J, Kavati A, Ortiz B, A Colby J, et al
    Efficacy and safety of omalizumab in children and adolescents with moderate-to-severe asthma: A systematic literature review.
    Allergy Asthma Proc. 2017 Jun 19. doi: 10.2500/aap.2017.38.4067.
    PubMed     Text format     Abstract available


    May 2017
  93. MANSFIELD L, Yiu G, Sakov A, Liu S, et al
    A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma.
    Allergy Asthma Proc. 2017 May 24. doi: 10.2500/aap.2017.38.4061.
    PubMed     Text format     Abstract available


  94. COOK KA, Lynch MT, Weis PJ, White AA, et al
    A 30-year-old woman with chronic hives, intermittent fevers, and joint pain.
    Allergy Asthma Proc. 2017;38:231-235.
    PubMed     Text format     Abstract available


  95. FOX J, Vegh AB, Martinez-Saguer I, Wuillemin WA, et al
    Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema.
    Allergy Asthma Proc. 2017;38:216-221.
    PubMed     Text format     Abstract available


  96. MANTI S, Leonardi S, Parisi GF, De Vivo D, et al
    High mobility group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate-severe asthma.
    Allergy Asthma Proc. 2017;38:197-203.
    PubMed     Text format     Abstract available


  97. PASHA MA, Sundquist B, Townley R
    Asthma pathogenesis, diagnosis, and management in the elderly.
    Allergy Asthma Proc. 2017;38:184-191.
    PubMed     Text format     Abstract available


  98. CHEHADE M, Sher E
    Medical therapy versus dietary avoidance in eosinophilic esophagitis: Which approach is better?
    Allergy Asthma Proc. 2017;38:170-176.
    PubMed     Text format     Abstract available


  99. TORCHYAN AA
    Asthma control in Saudi Arabia: Gender implications.
    Allergy Asthma Proc. 2017;38:47-53.
    PubMed     Text format     Abstract available


  100. CHOI S, Kim SH, Lee JS
    Association between depression and asthma in Korean adults.
    Allergy Asthma Proc. 2017;38:37-46.
    PubMed     Text format     Abstract available


  101. SYPNIEWSKA G, Krintus M, Fulgheri G, Siodmiak J, et al
    25-Hydroxyvitamin D, biomarkers of eosinophilic inflammation, and airway remodeling in children with newly diagnosed untreated asthma.
    Allergy Asthma Proc. 2017;38:29-36.
    PubMed     Text format     Abstract available


    January 2017
  102. CIPRANDI G, Gallo F, Ricciardolo FLM
    Uncontrolled asthma: A real-life experience.
    Allergy Asthma Proc. 2017;38:1-2.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: